MyFastRx Tirzepatide Review: Cost, a Verified Seal & Honest Verdict (2026)

MyFastRx has a genuine LegitScript seal (#24730) served directly from LegitScript's own CDN, alongside aggressive 12-month bundle pricing — as low as $149/month for tirzepatide. Every fact here comes from the company's own published program.

What MyFastRx is

MyFastRx is a cash-pay compounded-GLP-1 platform, built around fast approval and discounted multi-month bundles, serving all 50 states. LegitScript certified.

What MyFastRx costs

The standard rate is $249/month, but the 12-month bundle drops it to $149/month for tirzepatide — a genuinely aggressive rate, though it requires the full 12 months billed upfront. All doses are priced the same, so there's no cost escalation as you titrate up.

The brand-vs-compounded question

MyFastRx dispenses compounded tirzepatide only — cash-pay, no insurance billing. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

MyFastRx's real strengths: a genuinely verified LegitScript seal, plus all-doses-same pricing with no titration cost escalation, a first-month promo discount, and all-50-state availability. The trade-offs: the lowest bundle price requires a full 12-month upfront commitment, states served aren't specifically disclosed beyond "multiple states," the corporate address and medical director aren't published, and pharmacy partners aren't named beyond "state-licensed pharmacies." As with any GLP-1 program, and especially one requiring a large upfront bundle commitment, confirm you're comfortable with the full term before paying; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

MyFastRx's genuinely verified LegitScript seal and all-doses-same pricing are real strengths this review confirmed directly, but the lowest advertised rate requires a full 12-month upfront commitment — confirm you're comfortable with that before committing. For a similarly LegitScript-verified provider without the large upfront bundle requirement, compare it against NavioMD or CoreAge Rx. For an aggressively priced provider this review found had very thin public disclosure otherwise, see Piper. For a hybrid in-office-plus-telemed provider whose page shows no stated LegitScript certification, see Regenics. For a provider with a rare sublingual delivery option and unnamed pharmacy sourcing, see Remote Pharmacy. For a provider whose own homepage headline price this review found contradicts its actual catalog, alongside dead legal-document links, see Ryze Rx. For a provider with genuinely transparent flat and quarterly pricing but no LegitScript badge, see Somira Health. For a listing the ranking's own research flags as a low-confidence stub entry, see Super Healthy Rx. For a low-refill-price provider whose site also shows a separate, unclarified Medi Health Clinics brand, see TeleHealth Weight Solutions. For a solo-physician practice with a genuinely verified ABOM-certified doctor, but a self-hosted LegitScript badge, see TOM Weight Loss. For a small, owner-operated provider whose LegitScript claim this review's own live check couldn't render since the page is JavaScript-only, see Trillium Meds. For a provider with a genuinely named telehealth-physician-pharmacy chain, though this review's live check was blocked, see TrueMe. See our best tirzepatide providers ranking for the full field.